Episode Details
Back to EpisodesRetatrutide and the Rise of the "Triple G"
Description
Click here to join our Discord: Real Peptide Talk
Visit our store: https://NRGBioLabs.com
Visit our blog: https://peptideresearch.us
Join our Newsletter list: https://peptideresearch.us/newsletter
Follow us on Facebook
In this follow up episode, we break down why retatrutide is being called the "Triple G". We explain how combining GLP-1, GIP, and glucagon receptor activity may influence appetite, insulin response, and energy expenditure at the same time.
The conversation highlights published research showing weight reduction approaching 29 percent, near normalization of liver fat signals, improvements in triglycerides and blood pressure, and early quality of life markers like physical function and pain related outcomes.